ProShare Advisors’s Pfizer PFE Stock Holding History

ProShare Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.3M	Sell	863,798 -291,331	-25%	-$7.76M	0.04%	248
2025 Q4	$28.8M	Buy	1,155,129 +77,325	+7%	+$1.95M	0.05%	252
2025 Q3	$27.5M	Sell	1,077,804 -16,767	-2%	-$414K	0.06%	248
2025 Q2	$26.5M	Buy	1,094,571 +104,687	+11%	+$2.44M	0.05%	253
2025 Q1	$25.1M	Buy	989,884 +85,025	+9%	+$2.22M	0.06%	249
2024 Q4	$24M	Buy	904,859 +118,216	+15%	+$3.21M	0.05%	242
2024 Q3	$22.8M	Sell	786,643 -58,995	-7%	-$1.72M	0.06%	240
2024 Q2	$23.7M	Buy	845,638 +57,825	+7%	+$1.59M	0.06%	235
2024 Q1	$21.9M	Sell	787,813 -24,079	-3%	-$668K	0.06%	243
2023 Q4	$23.4M	Sell	811,892 -76,931	-9%	-$2.33M	0.07%	232
2023 Q3	$29.5M	Sell	888,823 -39,422	-4%	-$1.39M	0.09%	214
2023 Q2	$34M	Sell	928,245 -15,572	-2%	-$606K	0.1%	179
2023 Q1	$38.5M	Buy	943,817 +105,205	+13%	+$4.54M	0.12%	155
2022 Q4	$43M	Sell	838,612 -5,960	-0.7%	-$286K	0.15%	128
2022 Q3	$37M	Sell	844,572 -83,285	-9%	-$4.05M	0.14%	133
2022 Q2	$48.6M	Sell	927,857 -343,632	-27%	-$17.5M	0.16%	129
2022 Q1	$65.8M	Sell	1,271,489 -973	-0.1%	-$50.5K	0.14%	150
2021 Q4	$75.1M	Buy	1,272,462 +273,301	+27%	+$13.5M	0.15%	151
2021 Q3	$43M	Buy	999,161 +7,742	+0.8%	+$343K	0.12%	158
2021 Q2	$38.8M	Buy	991,419 +159,314	+19%	+$6.2M	0.11%	170
2021 Q1	$30.1M	Buy	832,105 +41,808	+5%	+$1.48M	0.09%	188
2020 Q4	$29.1M	Buy	790,297 +17,232	+2%	+$632K	0.11%	175
2020 Q3	$26.9M	Sell	773,065 -218,294	-22%	-$7.65M	0.12%	146
2020 Q2	$30.8M	Buy	991,359 +143,655	+17%	+$4.88M	0.16%	127
2020 Q1	$26.3M	Sell	847,704 -441,920	-34%	-$15.1M	0.19%	116
2019 Q4	$47.9M	Buy	1,289,624 +239,036	+23%	+$8.51M	0.22%	107
2019 Q3	$35.8M	Buy	1,050,588 +39,470	+4%	+$1.44M	0.2%	107
2019 Q2	$41.6M	Sell	1,011,118 -194,040	-16%	-$7.71M	0.25%	101
2019 Q1	$48.6M	Buy	1,205,158 +2,953	+0.2%	+$118K	0.29%	98
2018 Q4	$49.8M	Buy	1,202,205 +132,491	+12%	+$5.5M	0.35%	84
2018 Q3	$44.7M	Sell	1,069,714 -173,932	-14%	-$6.7M	0.3%	88
2018 Q2	$42.8M	Sell	1,243,646 -129,036	-9%	-$4.41M	0.29%	93
2018 Q1	$46.2M	Buy	1,372,682 +67,078	+5%	+$2.31M	0.3%	97
2017 Q4	$44.9M	Buy	1,305,604 +413,596	+46%	+$14.1M	0.31%	90
2017 Q3	$30.2M	Buy	892,008 +78,789	+10%	+$2.53M	0.28%	90
2017 Q2	$25.9M	Sell	813,219 -50,820	-6%	-$1.6M	0.26%	87
2017 Q1	$28M	Sell	864,039 -30,499	-3%	-$962K	0.29%	84
2016 Q4	$27.6M	Buy	894,538 +191,886	+27%	+$5.86M	0.31%	82
2016 Q3	$22.6M	Sell	702,652 -255,454	-27%	-$8.54M	0.32%	78
2016 Q2	$32M	Sell	958,106 -12,374	-1%	-$395K	0.41%	75
2016 Q1	$27.3M	Sell	970,480 -414,904	-30%	-$11.9M	0.38%	83
2015 Q4	$42.4M	Buy	1,385,384 +45,823	+3%	+$1.44M	0.51%	39
2015 Q3	$39.9M	Buy	1,339,561 +55,145	+4%	+$1.77M	0.56%	33
2015 Q2	$40.9M	Sell	1,284,416 -218,732	-15%	-$7.13M	0.57%	30
2015 Q1	$49.6M	Sell	1,503,148 -158,103	-10%	-$5.03M	0.58%	29
2014 Q4	$49.1M	Buy	1,661,251 +297,838	+22%	+$8.54M	0.57%	28
2014 Q3	$38.3M	Sell	1,363,413 -109,271	-7%	-$3.07M	0.51%	28
2014 Q2	$41.5M	Sell	1,472,684 -89,429	-6%	-$2.55M	0.54%	27
2014 Q1	$47.6M	Buy	1,562,113 +84,362	+6%	+$2.52M	0.6%	26
2013 Q4	$42.9M	Buy	1,477,751 +660,209	+81%	+$19.2M	0.64%	24
2013 Q3	$22.3M	Sell	817,542 -477,533	-37%	-$13M	0.53%	26
2013 Q2	$34.4M	Buy	+1,295,075	New	+$35.8M	0.68%	20

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

ProShare Advisors's PFE Position: Q1 2026 in Review

ProShare Advisors reduced its Pfizer (PFE) stake by 25% in Q1 2026, selling an estimated $7.76M and leaving 863,798 shares worth $24.3M. The position accounts for 0.04% of the portfolio, ranked #248.

ProShare Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $75.1M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

ProShare Advisors held 863,798 shares of Pfizer worth $24.3M as of Q1 2026.
ProShare Advisors sold 291,331 Pfizer shares in Q1 2026, an estimated $7.76M.
Pfizer made up 0.04% of ProShare Advisors's portfolio in Q1 2026, its #248 holding.
ProShare Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
ProShare Advisors's Pfizer position peaked at $75.1M in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.